News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurosearch A/S (NEUR.CO) Names Patrik Dahlen as the Company's New CEO



8/25/2010 8:39:32 AM

Pharmalive -- COPENHAGEN, 24 August 2010 – Today, NeuroSearch A/S (NEUR), a leading CNS focused and European based biopharmaceutical company announced the appointment of Patrik Dahlen as new CEO of the company. With effect from 15 September 2010, Patrik Dahlen will replace CEO Flemming Pedersen, who resigns to take up a new position in another company.

Read at PharmaLive


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES